Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients

John F Smyth, Charles Gourley, Graeme Walker, Melanie J MacKean, Alan Stevenson, Alistair R W Williams, Awatif Al-Nafussi, Tzyvia Rye, Ron Rye, Moira Stewart, Janet McCurdy, Max Mano, Nick Reed, Tracey McMahon, Paul Vasey, Hani Gabra, Simon P Langdon

Research output: Contribution to journalArticlepeer-review

Abstract

To evaluate the efficacy of the aromatase inhibitor letrozole in preselected estrogen receptor (ER)-positive relapsed epithelial ovarian cancer patients and to identify markers that predict endocrine-sensitive disease.
Original languageEnglish
Pages (from-to)3617-22
Number of pages6
JournalClinical Cancer Research
Volume13
Issue number12
DOIs
Publication statusPublished - 2007

Fingerprint

Dive into the research topics of 'Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients'. Together they form a unique fingerprint.

Cite this